Condition: Neoplasm Malignant · Sponsor: Merck Sharp & Dohme LLC
Researchers want to learn if calderasib given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many people have the cancer respond (get smaller or go away) to calderasib alone or with cetuximab and how these responses compare * About the safety of calderasib alone or with cetuximab and if people tolerate the treatments.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Greater Baltimore Medical Center ( Site 1104) | Baltimore, Maryland, United States | Recruiting |
| START Midwest ( Site 1103) | Grand Rapids, Michigan, United States | Recruiting |
| Comprehensive Cancer Centers of Nevada ( Site 1109) | Las Vegas, Nevada, United States | Recruiting |
| Rutgers Cancer Institute of New Jersey ( Site 1100) | New Brunswick, New Jersey, United States | Recruiting |
| START Mountain Region ( Site 1106) | West Valley City, Utah, United States | Recruiting |
| Virginia Cancer Specialists ( Site 1102) | Fairfax, Virginia, United States | Recruiting |
| Prince of Wales Hospital-Medical Oncology ( Site 1003) | Randwick, New South Wales, Australia | Recruiting |
| Westmead Hospital ( Site 1000) | Westmead, New South Wales, Australia | Recruiting |
| Epworth Freemasons ( Site 1004) | Melbourne, Victoria, Australia | Recruiting |
| Jewish General Hospital-CRU ( Site 2900) | Montreal, Quebec, Canada | Recruiting |
| FALP ( Site 1200) | Santiago, Region M. de Santiago, Chile | Recruiting |
| Centro de Oncología de Precisión ( Site 1202) | Santiago, Region M. de Santiago, Chile | Recruiting |
+ 52 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07209111